Evidence map›Paper›PMID 35722615›Full record

ArticleFrontiers in cellular neuroscience2022

Deletion of the Sodium-Dependent Glutamate Transporter GLT-1 in Maturing Oligodendrocytes Attenuates Myelination of Callosal Axons During a Postnatal Phase of Central Nervous System Development.

Elizabeth J Thomason, Edna Suárez-Pozos, Fatemah S Afshari, Paul A Rosenberg, Jeffrey L Dupree, Babette Fuss

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Lysophosphatidic acid signaling via LPAJournal of neurochemistry · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Elizabeth J ThomasonDepartment of Anatomy and Neurobiology, Virginia Commonwealth University School of Medicine, Richmond, VA, United States.
Edna Suárez-PozosDepartment of Anatomy and Neurobiology, Virginia Commonwealth University School of Medicine, Richmond, VA, United States.
Fatemah S AfshariDepartment of Anatomy and Neurobiology, Virginia Commonwealth University School of Medicine, Richmond, VA, United States.
Paul A RosenbergDepartment of Neurology and the F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, United States.
Jeffrey L DupreeDepartment of Anatomy and Neurobiology, Virginia Commonwealth University School of Medicine, Richmond, VA, United States.
Babette FussDepartment of Anatomy and Neurobiology, Virginia Commonwealth University School of Medicine, Richmond, VA, United States.
Virginia Commonwealth University · USBoston Children's Hospital · US

Funding

Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI SCOTT Loren POMEROY, MUSTAFA SAHIN · 2021 to 2026
$9.4M
Mechanisms in CNS myelination: Role of PD-lalpha/ATXR01NS045883 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI FUSS, BABETTE · 2004 to 2020
$4.5M
Glutamate transporters as regulators of CNS myelinationR21NS090901 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI FUSS, BABETTE · 2015 to 2016
$419k
NICHD NIH HHS P50 HD105351NINDS NIH HHS R01 NS045883NINDS NIH HHS R21 NS090901
6 · The paper itself

Abstract

The sodium-dependent glutamate transporter GLT-1 (EAAT2, SLC1A2) has been well-described as an important regulator of extracellular glutamate homeostasis in the central nervous system (CNS), a function that is performed mainly through its presence on astrocytes. There is, however, increasing evidence for the expression of GLT-1 in CNS cells other than astrocytes and in functional roles that are mediated by mechanisms downstream of glutamate uptake. In this context, GLT-1 expression has been reported for both neurons and oligodendrocytes (OLGs), and neuronal presynaptic presence of GLT-1 has been implicated in the regulation of glutamate uptake, gene expression, and mitochondrial function. Much less is currently known about the functional roles of GLT-1 expressed by OLGs. The data presented here provide first evidence that GLT-1 expressed by maturing OLGs contributes to the modulation of developmental myelination in the CNS. More specifically, using inducible and conditional knockout mice in which GLT-1 was deleted in maturing OLGs during a peak period of myelination (between 2 and 4 weeks of age) revealed hypomyelinated characteristics in the corpus callosum of preferentially male mice. These characteristics included reduced percentages of smaller diameter myelinated axons and reduced myelin thickness. Interestingly, this myelination phenotype was not found to be associated with major changes in myelin gene expression. Taken together, the data presented here demonstrate that GLT-1 expressed by maturing OLGs is involved in the modulation of the morphological aspects associated with CNS myelination in at least the corpus callosum and during a developmental window that appears of particular vulnerability in males compared to females.

Indexed as

conditional and inducible knockoutdevelopmentglutamate transportmyelinationoligodendrocyte

Identifiers

PMID35722615
PMCPMC9203689
OpenAlexW4281659232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.